BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 17905498)

  • 1. Scientific considerations for evaluating cancer bioassays conducted by the Ramazzini Institute.
    Gift JS; Caldwell JC; Jinot J; Evans MV; Cote I; Vandenberg JJ
    Environ Health Perspect; 2013; 121(11-12):1253-63. PubMed ID: 24045135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl tertiary-butyl ether mode of action for cancer endpoints in rodents.
    Cruzan G; Borghoff SJ; de Peyster A; Hard GC; McClain M; McGregor DB; Thomas MG
    Regul Toxicol Pharmacol; 2007 Mar; 47(2):156-65. PubMed ID: 17084497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MtBE and cancer in animals: statistical issues with poly-3 survival adjustments for lifetime studies.
    Kissling GE; Portier CJ; Huff J
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):428-9. PubMed ID: 17905498
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter to the editor: effects of MTBE on Leydig cell tumors in Sprague-Dawley rats: range of possible poly-3 results.
    Beck B
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):430. PubMed ID: 18423267
    [No Abstract]   [Full Text] [Related]  

  • 5. Carcinogenicity studies on MTBE: critical review and interpretation.
    Mennear JH
    Risk Anal; 1997 Dec; 17(6):673-81. PubMed ID: 9463924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subchronic studies in Sprague-Dawley rats to investigate mechanisms of MTBE-induced Leydig cell cancer.
    de Peyster A; MacLean KJ; Stephens BA; Ahern LD; Westover CM; Rozenshteyn D
    Toxicol Sci; 2003 Mar; 72(1):31-42. PubMed ID: 12604832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of MTBE on the reported incidence of Leydig cell tumors in Sprague-Dawley rats: range of possible Poly-3 results.
    Goodman JE; Gaylor D; Beyer LA; Rhomberg LR; Beck BD
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):273-84. PubMed ID: 18241965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The National Toxicology Program rodent bioassay: designs, interpretations, and scientific contributions.
    Bucher JR
    Ann N Y Acad Sci; 2002 Dec; 982():198-207. PubMed ID: 12562638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ramazzini Foundation cancer program: history and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results.
    Soffritti M; Belpoggi F; Minardi F; Maltoni C
    Ann N Y Acad Sci; 2002 Dec; 982():26-45. PubMed ID: 12562627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of long-term experimental studies on the carcinogenicity of methyl tert-butyl ether.
    Belpoggi F; Soffritti M; Filippini F; Maltoni C
    Ann N Y Acad Sci; 1997 Dec; 837():77-95. PubMed ID: 9472331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyl-tertiary-butyl ether (MTBE)--a gasoline additive--causes testicular and lymphohaematopoietic cancers in rats.
    Belpoggi F; Soffritti M; Maltoni C
    Toxicol Ind Health; 1995; 11(2):119-49. PubMed ID: 7491630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments.
    Portier CJ; Hedges JC; Hoel DG
    Cancer Res; 1986 Sep; 46(9):4372-8. PubMed ID: 3731095
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.